# A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

> **NCT00653822** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 75 (actual)

## Conditions studied

- Pharmacokinetics of Alefacept

## Interventions

- **DRUG:** alefacept
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00653822
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653822, "A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00653822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*